Cosentyx unoready 300 MG pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FWSVE
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,706
Award facts
- Contract value 100% obligated
- $24,705.89 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $24,705.89 to AmerisourceBergen Drug Corp for Cosentyx (secukinumab) 300 mg pen auto-injectors on September 10, 2025, with completion targeted for September 11, 2025. This competitive award, with no set-aside designation, utilizes firm fixed pricing and is fulfilled from the vendor's location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen Drug Corp's broader indefinite delivery contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement extending through December 2026 that serves as the primary pharmaceutical supply vehicle for military healthcare programs worldwide.
As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp supplies a comprehensive range of brand-name and generic medications, specialty pharmaceuticals, vaccines, and medical devices to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This Cosentyx delivery represents the company's continued role in providing specialty immunology medications within DLA's Medical Supply Chain. The DLA Troop Support is planning to transition to Generation V Pharmaceutical Prime Vendor Global Program contracts with multiple regional awards, positioning AmerisourceBergen Drug Corp among anticipated competing contractors under this next-generation procurement framework.
Quick answers
Who was awarded contract SPE2DB25FWSVE?
SPE2DB25FWSVE was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 10, 2025.
How much is contract SPE2DB25FWSVE worth?
The government has obligated $24,706 on SPE2DB25FWSVE.
Is contract SPE2DB25FWSVE an order under another contract?
Yes. SPE2DB25FWSVE is a delivery order under SPE2DB25D3007, an indefinite delivery contract.
Was contract SPE2DB25FWSVE competed?
The extent of competition for SPE2DB25FWSVE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award